Medera
PrivateLast Round
M&A
Feb 26, 2026
Est. Valuation
$100M
Total Funding Raised
$3.03M
Company Overview
Medera is a clinical-stage biopharmaceutical company that develops novel gene- and cell-based therapeutic candidates for cardiovascular, pulmonary, and vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medera Comparables
Compare Medera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| bit.bio | 84% | |
| Axol Bioscience | 84% | |
| Ncardia | 84% | |
Medera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Feb 26, 2026 | ||||
| Reverse Merger | Sep 5, 2024 | ||||
| M&A | Nov 18, 2020 | ||||
| Grant | Jan 7, 2020 | ||||
| Grant | Jun 6, 2018 | ||||
Grant | Feb 26, 2018 |
Key People
Founding team and executive leadership
Medera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hong Kong Science and Technology Park | Private Placement, VC Round |
| Innovation and Technology Commission | Grant |
| Keen Vision Acquisition Corporation | Reverse Merger, M&A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 126% MoM, from 3.9K to 8.9K.
- Jun 8, 2025
Grew 21% QoQ from 14 to 17 employees.
Medera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medera's valuation, stock price, and market status.